Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...
Almost before the judge's signature was dry on Friday's federal district court preliminary injunction in favor of Edwards Lifesciences Corp. (Irvine, CA) that will block Medtronic from selling its ...
MINNEAPOLIS (AP) — Medtronic has agreed to pay more than $1 billion to settle long-standing patent litigation with fellow medical device maker Edwards Lifesciences over replacement heart valves. The ...
Colibri Heart Valve sued Medtronic CoreValve alleging induced infringement of US Patent No. 8,900,294 (the ’294 patent), directed to methods of partially deploying an artificial heart valve so that ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A federal jury in California ...
Wall Street and others are continuing to weigh in on Medtronic Inc.’s pending $700 million buy of Irvine device maker CoreValve Inc. Medtronic, which employs some 550 people at its Santa Ana heart ...
Surgical aortic valve replacement (SAVR) devices are widely believed to be considerably more durable than transcatheter aortic valve replacement (TAVR) devices, but five-year data for Medtronic plc’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results